CN1268930C - Assembled magnetic composite micro particle, and its preparing method and use - Google Patents
Assembled magnetic composite micro particle, and its preparing method and use Download PDFInfo
- Publication number
- CN1268930C CN1268930C CN 03153486 CN03153486A CN1268930C CN 1268930 C CN1268930 C CN 1268930C CN 03153486 CN03153486 CN 03153486 CN 03153486 A CN03153486 A CN 03153486A CN 1268930 C CN1268930 C CN 1268930C
- Authority
- CN
- China
- Prior art keywords
- magnetic
- particles
- assembled
- magnetic composite
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims abstract description 14
- 239000011859 microparticle Substances 0.000 title claims abstract description 6
- 239000011246 composite particle Substances 0.000 claims abstract description 66
- 239000002245 particle Substances 0.000 claims abstract description 25
- 239000002923 metal particle Substances 0.000 claims abstract description 19
- 229910000510 noble metal Inorganic materials 0.000 claims abstract description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 13
- 239000006249 magnetic particle Substances 0.000 claims abstract description 13
- 108090001008 Avidin Proteins 0.000 claims abstract description 10
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 150000004676 glycans Chemical class 0.000 claims abstract description 10
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 10
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 10
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 10
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 10
- 239000005017 polysaccharide Substances 0.000 claims abstract description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 9
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 108010090804 Streptavidin Proteins 0.000 claims abstract description 9
- 239000012620 biological material Substances 0.000 claims abstract description 8
- 108090000790 Enzymes Proteins 0.000 claims abstract description 7
- 102000004190 Enzymes Human genes 0.000 claims abstract description 7
- -1 antibodies Proteins 0.000 claims abstract description 7
- 239000000427 antigen Substances 0.000 claims abstract description 7
- 102000036639 antigens Human genes 0.000 claims abstract description 7
- 108091007433 antigens Proteins 0.000 claims abstract description 7
- 229920001184 polypeptide Polymers 0.000 claims abstract description 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 7
- 229910052759 nickel Inorganic materials 0.000 claims abstract description 6
- 229910017052 cobalt Inorganic materials 0.000 claims abstract description 3
- 239000010941 cobalt Substances 0.000 claims abstract description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052742 iron Inorganic materials 0.000 claims abstract description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 3
- 229910052748 manganese Inorganic materials 0.000 claims abstract description 3
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 3
- 239000007769 metal material Substances 0.000 claims abstract description 3
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 3
- 229910006297 γ-Fe2O3 Inorganic materials 0.000 claims abstract description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 21
- 238000001514 detection method Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000007787 solid Substances 0.000 claims description 13
- 239000010419 fine particle Substances 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 12
- 239000010931 gold Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000007885 magnetic separation Methods 0.000 claims description 8
- 230000007935 neutral effect Effects 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 7
- 125000000524 functional group Chemical group 0.000 claims description 7
- 229910052737 gold Inorganic materials 0.000 claims description 7
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 6
- 239000007771 core particle Substances 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 230000004048 modification Effects 0.000 claims description 6
- 238000012986 modification Methods 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 229910052709 silver Inorganic materials 0.000 claims description 5
- 239000004332 silver Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000002122 magnetic nanoparticle Substances 0.000 claims description 4
- 239000002105 nanoparticle Substances 0.000 claims description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 claims description 3
- 239000012154 double-distilled water Substances 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- 238000006884 silylation reaction Methods 0.000 claims description 3
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 claims description 2
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- HQLZFBUAULNEGP-UHFFFAOYSA-N hexan-3-amine Chemical compound CCCC(N)CC HQLZFBUAULNEGP-UHFFFAOYSA-N 0.000 claims description 2
- VOIGMFQJDZTEKW-UHFFFAOYSA-N hexane-3-thiol Chemical compound CCCC(S)CC VOIGMFQJDZTEKW-UHFFFAOYSA-N 0.000 claims description 2
- 239000011553 magnetic fluid Substances 0.000 claims description 2
- 244000000010 microbial pathogen Species 0.000 claims description 2
- 229910052763 palladium Inorganic materials 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 229910052703 rhodium Inorganic materials 0.000 claims description 2
- 239000010948 rhodium Substances 0.000 claims description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 2
- 229910052707 ruthenium Inorganic materials 0.000 claims description 2
- 238000002444 silanisation Methods 0.000 claims description 2
- 239000010410 layer Substances 0.000 claims 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 239000000356 contaminant Substances 0.000 claims 2
- MBNRBJNIYVXSQV-UHFFFAOYSA-N 3-[diethoxy(methyl)silyl]propane-1-thiol Chemical compound CCO[Si](C)(OCC)CCCS MBNRBJNIYVXSQV-UHFFFAOYSA-N 0.000 claims 1
- ZDWQSEWVPQWLFV-UHFFFAOYSA-N C(CC)[Si](OC)(OC)OC.[O] Chemical compound C(CC)[Si](OC)(OC)OC.[O] ZDWQSEWVPQWLFV-UHFFFAOYSA-N 0.000 claims 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 claims 1
- 230000007613 environmental effect Effects 0.000 claims 1
- ZJLMKPKYJBQJNH-UHFFFAOYSA-N propane-1,3-dithiol Chemical compound SCCCS ZJLMKPKYJBQJNH-UHFFFAOYSA-N 0.000 claims 1
- 239000002356 single layer Substances 0.000 claims 1
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 claims 1
- 229910000859 α-Fe Inorganic materials 0.000 abstract 2
- 102000003951 Erythropoietin Human genes 0.000 description 12
- 108090000394 Erythropoietin Proteins 0.000 description 12
- 229940105423 erythropoietin Drugs 0.000 description 12
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000011258 core-shell material Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 6
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 4
- 239000002751 oligonucleotide probe Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000006148 magnetic separator Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 238000000975 co-precipitation Methods 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- CWAFVXWRGIEBPL-UHFFFAOYSA-N ethoxysilane Chemical compound CCO[SiH3] CWAFVXWRGIEBPL-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- SUVIGLJNEAMWEG-UHFFFAOYSA-N propane-1-thiol Chemical compound CCCS SUVIGLJNEAMWEG-UHFFFAOYSA-N 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Images
Abstract
The present invention relates to an assembly type magnetic composite micro particle and a preparing method and the application thereof. The magnetic composite particle is composed of a magnetic core part which has superparamagnetism and an assembly layer part, wherein the magnetic core part is composed of Fe3O4, gamma-Fe2O3, nanometer particles, ferrite, metal materials of iron, and/or nickel, and/or cobalt, etc. and/or aggregates of the nanometer particles; the structure formula of the ferrite is MeO. Fe2O3 (M is equal to Ni, Co, Mg and Zn, and Mn is an equal bivalent metal ion); the assembly layer part is composed of nanometer noble metal particles. The magnetic composite particle has the preparing method that the magnetic core part of the magnetic composite particle is processed by organic reagents, and the nanometer noble metal particles are assembled at the surface of the core magnetic particle. The magnetic composite particle can be used for marking biomolecules of nucleic acid, antigens, antibodies, enzyme, polypeptide, polysaccharide, avidin, streptavidin, etc., cells and non biological materials. The marked composite particle can be used for enriching, separating and detecting various organism and non organism molecules.
Description
Technical Field
The invention relates to an assembled magnetic composite particle and a preparation method and application thereof. Specifically, the invention relates to an assembled magnetic composite particle capable of labeling biological and non-biological materials such as nucleic acid, antigen, antibody, enzyme, polypeptide, polysaccharide, avidin or streptavidin, cells and the like, and a preparation method and application thereof. The assembled magnetic composite particle can be used as a marker and also can be used as a rapid enrichment means to be applied to the separation, purification and detection of various biological and non-biological molecules.
Background
Gold nanoparticles (colloidal gold) or silver nanoparticles (colloidal silver) have been widely used in immunohistochemistry, rapid antigen-antibody detection, nucleic acid hybridization detection, and the like, due to the characteristic of firm bonding with antibodies containing functional groups such as thiol groups, amino groups, and the like, and oligonucleotide probes modified with functional groups. The superparamagnetic iron oxide particles with the surface modified with functional groups have better magnetic responsiveness, and are also applied to separation, purification and detection of biomacromolecules. There have been few studies and products of composite materials that combine separability of magnetic particles and modifiability of biological or non-biological molecules on the surface of colloidal gold.
Primeri et al synthesized Fe of core/shell structure3O4Au superparamagnetic particles and mechanism of formation thereof (core/shell type Fe)3O4Preparation and mechanism of Au superparamagnetic particles, China science (edition B): 31(4): 319-324), the particles have uniform particle size, good monodispersity, good magnetic response and good biological molecule modification. Patent CN 03124061.5 discloses core-shell superparamagnetic composite particles, and a preparation method and application thereof (fig. 1 is a cross-sectional view of core-shell superparamagnetic composite particles). However, the magnetic composite particles with core-shell structure still need improvement in terms of biomolecule immobilization capacity and trace sample enrichment.
Aiming at the defects in the prior art, the invention provides a novel assembled magnetic composite particle.
Disclosure of Invention
The invention aims to provide an assembled magnetic composite particle which can mark biomolecules such as nucleic acid, antigen, antibody, enzyme, polypeptide, polysaccharide, avidin or streptavidin, cells or other non-biological materials and can be practically applied to separation, purification and detection of related bioactive substances or other substances.
Another object of the present invention is to provide a method for producing assembled magnetic composite fine particles.
Another object of the present invention is to use the assembled magnetic composite microparticles provided by the present invention for labeling biological molecules such as nucleic acids, antigens, antibodies, enzymes, polypeptides, polysaccharides, avidin, and streptavidin, or biological and non-biological materials such as cells.
The invention also aims to provide the application of the assembled magnetic composite particles in the fields of reaction systems of biomolecules such as antigen-antibody, DNA-DNA, DNA-oligonucleotide, ligand-receptor, avidin-biotin and the like or complex-metal pollutant environment monitoring, separation, purification and detection of biomolecules or other molecules in the fields of clinically pathogenic microorganisms such as bacteria, viruses and the like or food pollutants and the like.
The above-described object is achieved by the assembled magnetic composite fine particles according to the present invention. The assembled magnetic composite particle provided by the invention is composed of a core part and an assembly layer part, wherein the core part is a magnetic particle, and the assembly layer part is a nano-scale noble metal particle.
The core part of the assembled magnetic composite particles is Fe3O4、γ-Fe2O3Nano-scale particles of ferrate and/or metal materials such as iron, nickel, cobalt and the like and/or aggregates thereof; the nano-scale noble metal particles of the assembly layer part are gold, silver, palladium, platinum, ruthenium and rhodium.
The general structural formula of the ferrate of the core part of the assembled magnetic composite particles is MeO. Fe2O3Wherein Me is bivalent metal ions of Ni, Co, Mg, Zn and Mn.
The assembly layer part of the assembly type magnetic composite particles is that the nano-scale noble metal particles are gold or silver.
The particle size of the assembled magnetic composite particles is 0.05-100 μm; based on the total weight of the magnetic composite particle solid, the weight of the magnetic core part accounts for 70-99% of the total weight of the magnetic composite particle solid, and the weight of the assembly layer part accounts for 1-30% of the total weight of the magnetic composite particle solid.
The diameter of the metal particles in the assembly layer part of the assembly type magnetic composite particles is 5-100nm, the amount of the metal particles adsorbed to the magnetic core part is 5-50ml of noble metal particles/mg of the assembly type magnetic composite particles, and the assembly layer part is a single layeror a plurality of layers.
The preparation of the assembled magnetic composite particles is realized by the following scheme, and the method comprises the following steps:
a. the surface of the purchased or prepared superparamagnetic core particles is treated with an organic reagent: separating 25mL of superparamagnetic core particle suspension with solid content of 4mg/mL in magnetic field for 20 min, discarding supernatant, and adding H with volume ratio of 1: 12O∶C2H5Adding 250mL of OH mixed solvent, then adding 2mL of organic reagent, reacting for 10 hours at 50 ℃ for silanization treatment, carrying out magnetic separation, repeatedly washing with double distilled water to be neutral, and finally fixing the volume to 25 mL;
b. fully mixing the processed magnetic core particles with nano-scale metal particles with a certain volume, and assembling the mixture around the magnetic particles of the core part to obtain the assembled composite particles with stronger magnetic response performance: taking 30mL of the suspension obtained in the step a, magnetically separating the supernatant, adding 100mL of colloidal gold with the particle size of 20nm, and reacting on a shaker for 5-8 hours.
The preferred method comprises the steps of:
(1) preparation of the magnetic core part: mixing Fe2+、Mn2+、Ni2+、Zn2+Or Cu2+One ofAn aqueous solution of a metal salt and/or a mixture of several aqueous solutions of metal salts in a ratio of 1: 2 to 1: 4 with Fe3+After the salt water solution is mixed evenly, 1-6mol/l NaOH or 30% NH is added3·H2Adjusting the pH of the mixture to 10-13 with an alkali solution of O, rapidly stirring at 20 ℃ for 20-60 minutes, then heating to 60-70 ℃, continuing stirring and incubating for 30-60 minutes, separating a superparamagnetic particle precipitate in an external magnetic field, and washing with secondary distilled water to obtain neutral magnetic particles; then, diluting the magnetic particles with secondary distilled water to a constant volume to form a magnetic fluid, and forming a magnetic core part with the solid content of 5-20mg/ml, wherein the particle size of the magnetic core part is between 5nm and 10 mu m;
(2) surface modification of the magnetic core part: taking 1-10ml of the magnetic nanoparticles obtained in the step 1, carrying out magnetic separation, removing the upper layer solution, adding the magnetic nanoparticles into 1-100ml of a water/alcohol mixed solvent with the volume ratio of 1: 1-1: 5, then adding 20-1000 mu l of an organic reagent, reacting at the temperature of 20-80 ℃ for 0.5-24 hours, cooling to room temperature or a refrigerator at the temperature of 4 ℃, and washing with secondary water to be neutral to obtain a magnetic core;
(3) assembling noble metal particles on the surface of the magnetic core: and (3) adding noble metal sol with the mass ratio of 1: 20-1: 120 into the magnetic core obtained in the step (2), mixing on an air oscillator to form a surface assembly layer of the magnetic core part, magnetically separating, removing the solution on the upper layer, and repeatedly washing with secondary distilled water until the solution is neutral to obtain the assembled magnetic composite particles.
In the above preparation method, all the organic reagents are all the functional group-containing silylation reagents such as 3-aminopropyl-trimethoxysilane, 3-aminopropyl-triethoxysilane, 3-mercaptopropyl-trimethoxysilane and 3-mercaptopropyl-trimethoxysilane, or 3-mercaptopropane, 3-mercaptohexane, amino-containing 3-aminopropane and 3-aminohexane containing mercapto groups.
Compared with the prior art, theinvention has the following advantages:
the invention has great improvement on the fixed capacity of the biological molecules and the enrichment of trace samples. Compared with the magnetic composite particles with the core-shell structure, the assembled layer part of the assembled magnetic composite particles provided by the invention is nano-scale metal particles, so that the assembled magnetic composite particles have larger fixed capacity and stronger enrichment capacity on biological molecules. For example, for the fixation of avidin, 20-80 μ g of avidin can be fixed by 100 μ l of core-shell structure composite particles, and the amount of avidin which can be fixed by 100 μ l of assembly type composite particles can reach 200-300 μ g. Furthermore, 5-50ng of Erythropoietin (EPO) can be enriched in 20-50ml urine samples using a small amount of assembled composite microparticles coated with EPO antibody. This advantage has the same effect when immobilizing other molecules.
The assembled magnetic composite particle of the invention can be used for labeling biological and non-biological materials such as nucleic acid, oligonucleotide probe, antigen, antibody, enzyme, polypeptide, polysaccharide, avidin or streptavidin, cells and the like. The biological and non-biological materials such as nucleic acid, protein, polysaccharide and other biological molecules and other non-biological molecules marked by the assembled magnetic composite particles can be used for separation, purification and detection of the nucleic acid, the protein, the polysaccharide and other biological molecules.
The superparamagnetic composite particle has the advantages that the superparamagnetic particle is easy to separate under the action of a magnetic field, and the gold and silver surfaces are easy to combine with bioactive substances such as thiolated oligonucleotide, protein, polysaccharide and the like and are easy to modify, so that the superparamagnetic composite particle is very suitable for the enrichment and separation of biological and non-biological samples such as nucleic acid, protein and the like, the detection of nucleic acid hybridization and detection, antigen-antibody immunological detection and other biological systems, and can also be suitable for the field of food safety detection. Because the surface structure is different from the magnetic composite particles with the core-shell structure, the composite particles have strong responsiveness to an external magnetic field and larger fixed capacity to biomolecules, and reactants captured to the surfaces of the composite particles can be enriched, separated and purified only by one-step simple magnetic separation, so that the detection sensitivity and specificity are increased, and the detection time is shortened; the detection process is more convenient and fast, and simultaneously, the restriction of expensive detection instruments is eliminated.
Drawings
The invention will be further described with reference to the accompanying drawings.
Fig. 1 is a schematic cross-sectional structure diagram of a core-shell type superparamagnetic composite particle.
FIG. 2 is a schematic cross-sectional view of an assembled magnetic composite fine particle.
FIG. 3 is a graph showing the measurement of the particle size of the magnetic core portion modified with an organic reagent.
FIG. 4 is a dynamic monitoring curve of colloidal gold during the assembly of a magnetic core portion modified with functional groups.
Detailed Description
The following examples are merely illustrative of the practice of the present invention and are not intended to limit the scope of the invention.
In the figure, the characteristic peak of 520nm is the maximum absorption peak of the colloidal gold, and the curve in the figure shows that the maximum absorption peak of the colloidal gold gradually decreases with the time, which proves that the colloidal gold in the system is gradually assembled on the surface of the magnetic core part.
Example 1
This example is intended to illustrate the feasibility of the preparation of the assembled superparamagnetic composite particles of the present invention, and fig. 2 is a cross-sectional view of the assembled superparamagnetic composite particles prepared in this example.
1. Superparamagnetic Fe3O4And (3) synthesis of the particles:
chemical coprecipitation method for synthesizing Fe3O4The equation of (1) is:
taking Fe2+∶Fe3+50ml of a mixed solution of iron salts (1: 1.5) was added with 100ml of 1mol/l NaOH under sufficiently stirring, the pH was adjusted to 9 to 10, the reaction was carried out at room temperature for 20 minutes, and then the mixture was heated to 65 to 75 ℃ and aged for 30 minutes. Produced Fe3O4The seed particles are separated by a magnetic separator and then repeatedly washed to neutrality by high-purity water. Measuring the solid content for later use. The magnetic cores synthesized by the chemical coprecipitation method are all nano-scale particles, but when the magnetic cores are dispersed in water, the particles are aggregated to form aggregates within the range of 1-10 mu m due to strong interaction amongthe particles.
2. Surface modification of the magnetic core:
25ml of Fe with solid content of 4mg/ml is taken3O4The suspension is separated in a magnetic field for 20 minutes,discard the supernatant and add H2O∶C2H5About 250ml of mixed solvent of OH (volume ratio 1: 1), then adding 2ml of trimercaptopropyl-3 ethoxysilane, reacting for 10 hours at 50 ℃ to perform silanePerforming chemical treatment, performing magnetic separation, repeatedly washing with double distilled water to neutrality, and finally fixing the volume. Fig. 3 shows the measurement results of the particle size.
3. Synthesis of assembled magnetic composite microparticles
Taking 30ml of magnetic particles (solid content is 4mg/ml) with the surface modified with functional groups, magnetically separating the supernatant, adding 100ml of colloidal gold with the particle size of 20nm, and reacting on an oscillator for 5-8 hours to assemble the particles on the surfaces of the magnetic particles. The assembly process of colloidal gold on the surface of the silanized magnetic particles can be confirmed by observing the process that the intensity of the absorption peak of colloidal gold at 520nm decreases with time. In fig. 4, the characteristic peak at 520nm is the maximum absorption peak of the gold colloid, and the curve in the figure represents that the maximum absorption peak of the gold colloid gradually decreases with time from top to bottom, which indicates that the gold colloid in the system gradually assembles on the surface of the magnetic core part.
Example 2
This example is intended to demonstrate the modification of streptavidin by the assembled superparamagnetic composite particles of the present invention.
Fe3O4Mu.l of Au magnetic composite particle suspension with 0.1mol/l concentration of K2CO3Adjusting pH to 7.0 with water solution, balancing for 2-3 times, magnetically separating, and removing supernatant. Mu.l of 1. mu.g/. mu.l streptavidin solution (dissolved in 0.1mol/l PBS with pH 7.0, i.e. phosphate buffer) 150. mu.l is taken, placed in the magnetic composite particles, mixed uniformly and reflected in a rotary mixer for 30 minutes. The magnetic separation and repeated washing with a washing solution were performed, and the resulting solution was blocked with a buffer containing 1% Bovine Serum Albumin (BSA) and stored in a refrigerator at 4 ℃ until use.
Example 3
This example is intended to demonstrate that the surface of the assembled superparamagnetic composite particles of the present invention can be coupled with oligonucleotide probes by a conventional method.
After 10. mu.l of the assembled superparamagnetic composite particle suspension (4. mu.g/. mu.l) was mixed with the terminal thiol-modified oligonucleotide probe to make the final concentration of the probe 5. mu.M, and reacted for 10 hours, the mixed solution was placed in 10mM phosphate buffer (pH 7.0) containing 0.1M NaCl and further reacted for 6 to 8 hours, and the reacted mixture was separated with a magnetic separator, washed with 10mM phosphate buffer (pH 7.0) containing 0.1M NaCl, and stored in 10mM phosphate buffer (pH 7.0) containing 0.3M NaCl.
Example 4
This example is intended to illustrate the surface modification of an EPO antibody on the assembled superparamagnetic composite particles of the present invention and the method of using the antibody-immobilized assembled magnetic composite particles for EPO detection.
Immobilization of EPO antibody: 0.1ml of the assembled superparamagnetic composite particle suspension was taken, the supernatant was magnetically separated and discarded, 0.5ml of 0.05M Tris-HCl buffer (Tris-HCl) (pH 7.6) was added, the mixture was equilibrated for 5 minutes, and the supernatant was magnetically separated and discarded. To the composite fine particles, 200. mu.g of EPO antibody (0.05M Tris-HCl, pH 7.6) was added, mixed, reacted for 30 minutes, and shaken intermittently. The reacted mixture was separated with a magnetic separator, washed with a buffer solution, blocked with 1% BSA buffer, and stored. Measurement of OD280 (optical density absorption at 280nm in the ultraviolet region) before and after immobilization of the antibody on the surface of 100. mu.l of the assembly-type composite fine particle revealed that the amount of the antibody immobilized was as high as 100. mu.g.
The assembled superparamagnetic composite particle is used for enriching and measuring EPO in urine samples:
taking a certain amount of assembled superparamagnetic composite particles (containing 1000-5000ng antibody) fixed with EPO antibody into a detection container, adding 20ml of detected urine sample for full reaction, enriching EPO in the urine sample, carrying out magnetic separation, removing supernatant, then adding horseradish peroxidase (HRP) -labeled EPO antibody, washing for 2-3 times after reacting for 20 minutes, adding chromogenic substrate for reaction, measuring OD450 (optical density absorption value at 450nm of a visible region) value, and determining the amount of detected EPO.
Claims (11)
1. An assembled magnetic composite particle capable of labeling nucleic acids, antigens, antibodies, enzymes, polypeptides, polysaccharides, avidin, streptavidin biomolecules or cells and non-biological materials, comprising: the magnetic composite particle is composed of a core part with superparamagnetism and an assembly layer part, wherein the core part is a magnetic particle, and the assembly layer part is a nano-scale noble metal particle.
2. The assembled magnetic composite particle according to claim 1, wherein: the core part of the assembled magnetic composite particles is Fe3O4、γ-Fe2O3Nano-sized particles of ferrate and/or iron, nickel, cobalt metal materials and/or aggregates thereof; the nano-scale noble metal particles of the assembly layer part are gold, silver, palladium, platinum, ruthenium and rhodium.
3. The assembled magnetic composite fine particle according to claim 1 or 2, wherein: the structural general formula of the ferrate of the core part is MeO. Fe2O3Me is bivalent metal ions of Ni, Co, Mg, Zn and Mn.
4. The assembled magnetic composite fine particles according to claim 1 or 2, wherein the assembled layer portion of the assembled magnetic composite fine particles is formed by nano-scale noble metal particles of gold or silver.
5. The assembled magnetic composite fine particle according to claim 1 or 2, wherein: the assembled magnetic composite particles have a particle size of 0.05 to 100 μm; based on the total weight of the magnetic composite particle solid, the weight of the magnetic core part accounts for 70-99% of the total weight of the magnetic composite particle solid, and the weight of the assembly layer part accounts for 1-30% of the total weight of the magnetic composite particle solid.
6. The assembled magnetic composite fine particle according to claim 1 or 2, wherein: the diameter of the metal particles in the assembly layer part is 5-100nm, the amount of the metal particles adsorbed to the magnetic core part is 5-50ml noble metal particles/mg assembly type magnetic composite fine particles, and the assembly layer part is a single layer or a plurality of layers.
7. A method for preparing the assembled magnetic composite fine particles according to claim 1 or 2, comprising the steps of:
a. the surface of the purchased or prepared superparamagnetic core particles is treated with an organic reagent: 25mL of a suspension of superparamagnetic core particles with a solids content of 4mg/mL are taken. After separation in a magnetic field for 20 minutes, the supernatant was discarded and H was added in a volume ratio of 1: 12O∶C2H5Adding 250mL of OH mixed solvent, then adding 2mL of organic reagent, reacting at 50 ℃ for 10 hours, performing silanization treatment and magnetic separation, repeatedly washing with double distilled water to be neutral, and finally fixing the volume to 25 mL;
b. fully mixing the processed magnetic core particles with nano-scale metal particles with a certain volume, and assembling the mixture around the magnetic particles of the core part to obtain the assembled composite particles with stronger magnetic response performance: taking 30mL of the suspension obtained in the step a, magnetically separating the supernatant, adding 100mL of colloidal gold with the particle size of 20nm, and reacting on a shaker for 5-8 hours.
8. The method of producing assembled magnetic composite particles according to claim 6, comprising the steps of:
(1) preparation of the magnetic core part: mixing Fe2+、Mn2+、Ni2+、Zn2+Or Cu2+Gold of(1)Aqueous solutions of metal salts and/or mixtures of several aqueous solutions of metal salts in a ratio of 1: 2 to 1: 4 with Fe3+After the saline solution is uniformly mixed, adding 1-6mol/l NaOH or 30% NH 3. H2O alkali liquor, adjusting the pH of the mixture to 10-13, rapidly stirring for 20-60 minutes at 20 ℃, then heating to 60-70 ℃, continuing stirring and incubating for 30-60 minutes, separating out superparamagnetic particle precipitate in an external magnetic field, and washing with secondary distilled water to obtain neutral magnetic particles; then, diluting the magnetic particles with secondary distilled water to a constant volume to form a magnetic fluid, and forming a magnetic core part with the solid content of 5-20mg/ml, wherein the particle size of the magnetic core part is between 5nm and 10 mu m;
(2) surface modification of the magnetic core part: taking 1-10ml of the magnetic nanoparticles obtained in the step 1, carrying out magnetic separation, removing the upper layer solution, adding the magnetic nanoparticles into 1-100ml of a water/alcohol mixed solvent with the volume ratio of 1: 1-1: 5, then adding 20-1000 mu l of an organic reagent, reacting at the temperature of 20-80 ℃ for 0.5-24 hours, cooling to room temperature or a refrigerator at the temperature of 4 ℃, and washing with secondary water to be neutral to obtain a magnetic core;
(3) assembling noble metal particles on the surface of the magnetic core: and (3) adding noble metal sol with the mass ratio of 1: 20-1: 120 into the magnetic core obtained in the step (2), mixing on an air oscillator to form a surface assembly layer of the magnetic core part, magnetically separating, removing the solution on the upper layer, and repeatedly washing with secondary distilled water until the solution is neutral to obtain the assembled magnetic composite particles.
9. The method of claim 7, wherein: the organic reagent is a silylation reagent containing functional groups of 3-aminopropyl-trimethoxysilane, 3-aminopropyl-triethoxysilane, 3-mercaptopropyl-trimethoxysilane, mercaptopropyl-methyldiethoxysilane and glycidol ether oxygen propyl trimethoxysilane or a silylation reagent containing mercapto 3-mercaptopropane, 3-mercaptohexane, amino 3-aminopropane and 3-aminohexane.
10. Use of the assembled magnetic composite microparticles of claim 1 or 2 for labeling nucleic acids, antigens, antibodies, enzymes, polypeptides, polysaccharides, avidin, streptavidin biomolecules or cells and non-biological materials.
11. The assembled magnetic composite particle according to claim 1 or 2, wherein the assembled magnetic composite particle is used for the environmental monitoring of antigen-antibody, DNA-DNA, DNA-oligonucleotide, ligand-receptor, avidin-biotin biomolecule reaction system or complex-metal contaminant, and the enrichment, separation, purification and detection of biomolecule in the field of bacteria, virus clinical pathogenic microorganism or food contaminant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03153486 CN1268930C (en) | 2003-08-14 | 2003-08-14 | Assembled magnetic composite micro particle, and its preparing method and use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03153486 CN1268930C (en) | 2003-08-14 | 2003-08-14 | Assembled magnetic composite micro particle, and its preparing method and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1580765A CN1580765A (en) | 2005-02-16 |
| CN1268930C true CN1268930C (en) | 2006-08-09 |
Family
ID=34580079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03153486 Expired - Lifetime CN1268930C (en) | 2003-08-14 | 2003-08-14 | Assembled magnetic composite micro particle, and its preparing method and use |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1268930C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008089666A1 (en) * | 2007-01-19 | 2008-07-31 | Tianjin Medical University | A high-throughput detect technique for protein or nucleic acid――multi-forms of suspended micro-granular bioreactor |
| CN101165173B (en) * | 2006-10-19 | 2010-09-29 | 陕西西大北美基因股份有限公司 | Method for carrying cell sorting by using gold magnetism particles |
| CN101893627A (en) * | 2010-07-08 | 2010-11-24 | 崔亚丽 | Rapid detection method based on gold magnetic particle-labeled immunochromatography |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1952659B (en) * | 2005-10-19 | 2011-09-14 | 陕西北美基因股份有限公司 | An avidin/ streptavidin magnetic complex particle and the process thereof and purpose thereof |
| CN101165182B (en) * | 2006-10-19 | 2010-05-12 | 陕西西大北美基因股份有限公司 | Method for purifying DNA by using gold magnetism particles |
| CN101164621B (en) * | 2006-10-19 | 2010-05-12 | 陕西西大北美基因股份有限公司 | Super-paramagnetic composite particle drug-loaded body and preparation method thereof |
| CN101165183B (en) * | 2006-10-19 | 2010-05-12 | 陕西西大北美基因股份有限公司 | Method for separating mRNA by using gold magnetism particles |
| CN101303342B (en) * | 2008-07-03 | 2012-05-23 | 中国科学院长春应用化学研究所 | Antibody-gold case iron core magnetic nanometer particle synthetic method for cell recognition and separation |
| US20120121717A1 (en) * | 2008-12-30 | 2012-05-17 | Xi'an Goldmag Nanobiotech Co. Ltd | DRUG-LOADED POLYSACCHARIDE-COATED GOLDMAG PARTICLES (DPGPs) AND ITS SYNTHESIS METHOD |
| CN102565411B (en) * | 2010-12-08 | 2014-05-28 | 中国科学院生物物理研究所 | New method for tracing magnetic nano granules |
| CN102147358B (en) * | 2011-01-21 | 2012-11-28 | 东南大学 | Biological detection method based on nano-palladium label and catalytic deposition amplification function thereof |
| TW201303296A (en) * | 2011-07-14 | 2013-01-16 | Magqu Co Ltd | Reagent and method for detecting aquatic animal virus |
| CN102721804A (en) * | 2012-05-29 | 2012-10-10 | 西安金磁纳米生物技术有限公司 | Electrical chemiluminescence immunoassay based on gold magnetic particles |
| CN106782967A (en) * | 2017-02-28 | 2017-05-31 | 必欧瀚生物技术（合肥）有限公司 | A kind of magnetic bead of modified by silver nanoparticles, its preparation method and application |
| CN108821353A (en) * | 2018-08-01 | 2018-11-16 | 济南大学 | A kind of RuO2-LaFeO3The preparation method of nanocomposite |
-
2003
- 2003-08-14 CN CN 03153486 patent/CN1268930C/en not_active Expired - Lifetime
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101165173B (en) * | 2006-10-19 | 2010-09-29 | 陕西西大北美基因股份有限公司 | Method for carrying cell sorting by using gold magnetism particles |
| WO2008089666A1 (en) * | 2007-01-19 | 2008-07-31 | Tianjin Medical University | A high-throughput detect technique for protein or nucleic acid――multi-forms of suspended micro-granular bioreactor |
| CN101893627A (en) * | 2010-07-08 | 2010-11-24 | 崔亚丽 | Rapid detection method based on gold magnetic particle-labeled immunochromatography |
| CN101893627B (en) * | 2010-07-08 | 2014-12-17 | 崔亚丽 | Rapid detection method based on gold magnetic particle-labeled immunochromatography |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1580765A (en) | 2005-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1268930C (en) | Assembled magnetic composite micro particle, and its preparing method and use | |
| US7175912B2 (en) | Super-paramagnetic composite particle with core/shell structure, preparation method and use thereof | |
| Aguilar-Arteaga et al. | Magnetic solids in analytical chemistry: a review | |
| EP3043905B1 (en) | New diagnostic assay using particles with magnetic properties | |
| CN113333024B (en) | Magnetic nano enzyme material with peroxidase catalytic activity, kit for detecting norovirus and application thereof | |
| US20100209946A1 (en) | Uses of water-dispersible silica nanoparticles for attaching biomolecules | |
| KR102021663B1 (en) | Method of detecting a target material using magnetic bead based enzyme-mimic nanozyme | |
| WO2018082405A1 (en) | Concentration detection method for multiple target molecules | |
| KR20130040715A (en) | Method for preparing multi-functional biomolecular conjugates using two kinds of particle and multi-functional biomolecular conjugates prepared therefrom | |
| Liu et al. | A novel aptamer-mediated CuInS 2 quantum dots@ graphene oxide nanocomposites-based fluorescence “turn off–on” nanosensor for highly sensitive and selective detection of kanamycin | |
| Zhang et al. | A reusable piezoelectric immunosensor using antibody-adsorbed magnetic nanocomposite | |
| KR101277696B1 (en) | Methods for Separating, Concentrating and Detecting Microorganisms in One-Step Using Targeting-Gold Magnetic Nanoparticles | |
| CN112326623A (en) | Silicon-core-silver-shell composite nano label marked by double-layer Raman molecules, preparation method and immunochromatography application | |
| KR102341666B1 (en) | Microparticles for detecting biomaterials and method of detecting biomaterials using the same | |
| CN111650379A (en) | Preparation and immunochromatography application of gold shell magnetic Raman-enhanced nano tag | |
| Sánchez-Pomales et al. | Recent advances in electrochemical glycobiosensing | |
| JP2007078595A (en) | Functional particle and its manufacturing method | |
| KR101884061B1 (en) | electrode for label-free electrochemical immunobiosensor, manufacturing method thereof and label-free electrochemical immunobiosensor using thereof | |
| CN114459877A (en) | DNA tetrahedral composite magnetic nano material for enriching exosome and preparation | |
| JP2006169623A (en) | Functional particle and its production method | |
| Wang et al. | Aspects of recent development of immunosensors | |
| Bagherzadeh | Functionalized MNPs in detection stage of analysis/miniaturization devices | |
| KR20110115659A (en) | Carbon nanotube complex coated by porous metal oxide nanostructure and use thereof | |
| Ren et al. | Glucose oxidase-doped magnetic silica nanostrutures as labels for localized signal amplification of electrochemical immunosensors | |
| CN112526120A (en) | Method for detecting salbutamol based on SPR technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: XI'AN GOLDMAG NANOBIOTECH Co.,Ltd. Assignor: Shaanxi North American Gene Co.,Ltd. Contract record no.: 2011610000173 Denomination of invention: Assembled magnetic composite micro particle, and its preparing method and use Granted publication date: 20060809 License type: Exclusive License Open date: 20050216 Record date: 20110913 |
|
| ASS | Succession or assignment of patent right |
Owner name: XI'AN GOLDMAG NANOBIOTECH CO., LTD. Free format text: FORMER OWNER: SHAANXI BAIMEI GENE CO., LTD. Effective date: 20130906 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C56 | Change in the name or address of the patentee |
Owner name: SHAANXI BAIMEI GENE CO., LTD. Free format text: FORMER NAME: SHAANXI LIFEGEN CO., LTD. Owner name: SHAANXI LIFEGEN CO., LTD. Free format text: FORMER NAME: XIDA BEIMEI GENE CO., LTD., SHANXI |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 710000 XI'AN, SHAANXI PROVINCE TO: 710077 XI'AN, SHAANXI PROVINCE |
|
| CP03 | Change of name, title or address |
Address after: 386 mailbox, Northwestern University, Shaanxi, Xi'an 710000, China Patentee after: SHAANXI LIFEGEN Co.,Ltd. Address before: 386 mailbox, Northwestern University, Shaanxi, Xi'an, China Patentee before: Shaanxi North American Gene Co.,Ltd. Address after: 386 mailbox, Northwestern University, Shaanxi, Xi'an 710000, China Patentee after: Shaanxi North American Gene Co.,Ltd. Address before: 386 mailbox, Northwestern University, Shaanxi, Xi'an, China Patentee before: Shanxi Lifegen Co.,Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130906 Address after: 710077, Shaanxi, Xi'an hi tech Zone, No. 85, No. 4, No. 2, modern enterprise center, 3 east side, 10402A Patentee after: XI'AN GOLDMAG NANOBIOTECH Co.,Ltd. Address before: 386 mailbox, Northwestern University, Shaanxi, Xi'an 710000, China Patentee before: SHAANXI LIFEGEN Co.,Ltd. |
|
| CX01 | Expiry of patent term |
Granted publication date: 20060809 |
|
| CX01 | Expiry of patent term |